Targeting triple negative breast cancer stem cells using nanocarriers

被引：0
作者：
Nagasen Dasari
Girija Sankar Guntuku
Sai Kiran S. S. Pindiprolu
机构：
[1] Andhra University College of Pharmaceutical Sciences,
[2] Andhra University,undefined
[3] Aditya Pharmacy College,undefined
[4] Jawaharlal Nehru Technological University,undefined
来源：
Discover Nano | / 19卷
关键词：
Breast cancer stem cells; Molecular targets; Nano carriers; Anti-BSCS agents;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 1047 条
  • [1] Trayes KP(2021)Breast cancer treatment Am Fam Physician 104 171-178
  • [2] Cokenakes SEH(2021)The matrix in cancer Nat Rev Cancer 21 217-238
  • [3] Cox TR(2023)St Gallen Consensus Conference Panelists 2023. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 Ann Oncol 34 970-986
  • [4] Curigliano G(2023)Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer Mol Cancer 22 105-7
  • [5] Burstein HJ(2022)Breast cancer: presentation, investigation and management Br J Hosp Med (Lond) 83 1-16
  • [6] Gnant M(2021)Epidemiology of triple-negative breast cancer: a review Cancer J 27 8-1762
  • [7] Loibl S(2022)New therapy strategies in the management of breast cancer Drug Discov Today 27 1755-165
  • [8] Cameron D(2022)Disparities in breast cancer Obstet Gynecol Clin North Am 49 149-327
  • [9] Regan MM(2023)Recent advances in targeted strategies for triple-negative breast cancer J Hematol Oncol 16 100-898
  • [10] Denkert C(2023)The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC) Biomed Pharmacother 165 309-292
12345678910